{"id":575381,"date":"2026-08-05T09:16:11","date_gmt":"2026-08-05T09:16:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/575381\/"},"modified":"2026-08-05T09:16:11","modified_gmt":"2026-08-05T09:16:11","slug":"springer-nature-content-integrated-into-openevidence-under-new-agreement","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/575381\/","title":{"rendered":"Springer Nature content integrated into OpenEvidence under new agreement"},"content":{"rendered":"<p>\t\t\t\t<img width=\"466\" height=\"311\" src=\"https:\/\/www.newsbeep.com\/il\/wp-content\/uploads\/2026\/08\/shutterstock_2149270921.jpeg\" class=\"entry__image entry__image--orientation-landscape entry__image--size-large\" alt=\"\" decoding=\"async\" loading=\"lazy\"  \/>Shutterstock.com\/Sayan Puangkham\t\t\t<\/p>\n<p><a href=\"https:\/\/researchinformation.us14.list-manage.com\/subscribe?u=024658ece92678f8db736196e&amp;id=72bc247027\" rel=\"nofollow noopener\" target=\"_blank\">Be first to read the lastest industry news and analysis! SUBSCRIBE to the Research Information Newsline!<\/a><\/p>\n<p class=\"isSelectedEnd\">Springer Nature has announced a new subscription agreement with OpenEvidence that will make its peer-reviewed scientific and medical content available through the AI-powered clinical decision support platform.<\/p>\n<p class=\"isSelectedEnd\">The agreement enables physicians using OpenEvidence to retrieve and cite Springer Nature content while treating patients, giving healthcare professionals access to trusted research at the point of care through a platform already embedded in many clinical workflows.<\/p>\n<p class=\"isSelectedEnd\">The partnership also forms part of Springer Nature\u2019s community-led ARC3 framework, which is designed to support responsible access to research while ensuring appropriate attribution to authors and links back to the original published source.<\/p>\n<p class=\"isSelectedEnd\">Frank Vranken Peeters, Chief Executive Officer at Springer Nature, said: \u201cSpringer Nature and OpenEvidence share a common goal \u2013 to achieve maximum exposure for scientific research, while ensuring authors receive clear attribution and that their work is connected back to its original source. By partnering with OpenEvidence, one of the leading services delivering clinical findings at the point of care for healthcare professionals, we can help clinicians access trusted research, therefore supporting better-informed decisions and greater real-world impact.\u201d<\/p>\n<p class=\"isSelectedEnd\">Under the agreement, clinicians will be able to access peer-reviewed research from Springer Nature directly within OpenEvidence, helping them incorporate the latest scientific and medical evidence into patient care without leaving the platform.<\/p>\n<p class=\"isSelectedEnd\">Daniel Nadler, Chief Executive Officer of OpenEvidence, said: \u201cSpringer Nature publishes many of the world\u2019s most influential medical journals, books, and society publications. Bringing clinical findings from the Springer Nature portfolio into OpenEvidence widens the range of questions a physician can get a deeper sourced answer to, across every major area of medicine. And, in the process, connects the authors of practice-changing medicine and research with the clinicians who use it.\u201d<\/p>\n<p>Springer Nature said the agreement will also benefit researchers by increasing the visibility and use of their work, while ensuring content is accessed within a framework that provides attribution and directs users back to the original source.<\/p>\n<p><a href=\"https:\/\/researchinformation.us14.list-manage.com\/subscribe?u=024658ece92678f8db736196e&amp;id=72bc247027\" rel=\"nofollow noopener\" target=\"_blank\">Be first to read the lastest industry news and analysis! SUBSCRIBE to the Research Information Newsline!<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Shutterstock.com\/Sayan Puangkham Be first to read the lastest industry news and analysis! SUBSCRIBE to the Research Information Newsline!&hellip;\n","protected":false},"author":2,"featured_media":575382,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[85,46,125],"class_list":["post-575381","post","type-post","status-publish","format-standard","has-post-thumbnail","category-technology","tag-il","tag-israel","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/575381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=575381"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/575381\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/575382"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=575381"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=575381"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=575381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}